CC vs OLN vs CE Stock Comparison

Chemours, Olin and Celanese Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (KRO) Create a free account to keep reading and compare up to 10 companies.
CC Chemours Co
$13.28 +3.3% 1M +8.2% 1Y
Market cap
$1.89B
P/E
–
Revenue (TTM)
$5.84B
Div. yield
0.03%
Commodity Chemicals Basic Materials
3 wins
OLN OLIN Corp
$17.46 +16.2% 1M -15.9% 1Y
Market cap
$1.94B
P/E
–
Revenue (TTM)
$6.74B
Div. yield
–
Commodity Chemicals Basic Materials
CE Celanese Corp
$51.41 +12.2% 1M +28.6% 1Y
Market cap
$5.39B
P/E
20.6x
Revenue (TTM)
$9.85B
Div. yield
0.00%
Commodity Chemicals Basic Materials
8 wins

Head to Head

11 decided of 12

Celanese leads on 8 of the 12 questions below (Celanese 8, Chemours 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCCOLNCELeader
Larger companyMarket capitalisation $1.89B $1.94B $5.39B CE
Cheaper on earningsLower P/E, profitable companies only -12.3x -8.6x 20.6x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.1x — 8.0x CE
Faster revenue growthRevenue growth, trailing twelve months +0.1% -0.7% +1.6% CE
More profitableNet margin, trailing twelve months -2.6% -3.3% 2.7% CE
Better return on capitalReturn on invested capital 0.0% -2.1% 4.1% CE
Less leveragedLower net debt / EBITDA 8.6x 8.0x 6.2x CE
Higher dividend yieldTrailing dividend yield 0.03% 0.00% 0.00% CC
Better 1-year returnPrice return, last 12 months +8.2% -15.9% +28.6% CE
Better 5-year returnAnnualised price return, 5 years -16.7%/yr -23.0%/yr -21.3%/yr CC
Less volatileAnnualised volatility, 1 year 61.9% 52.7% 49.6% CE
Higher overall scoreMean of the five percentile scores vs peers 49/100 44/100 42/100 CC

Percentile Scorecard

CCOLNCE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCCOLNCE
Valuation 57 #42 of 96 78 #22 of 96 80 #20 of 96
Growth 88 #12 of 92 4 #88 of 92 25 #69 of 92
Profitability 41 #53 of 89 34 #59 of 89 59 #37 of 89
Financial Health 18 #79 of 96 17 #80 of 96 16 #81 of 96
Shareholder Returns 40 #48 of 79 87 #11 of 79 31 #55 of 79
Overall 49 44 42
  • CC ranked among 99 companies in Chemicals
  • OLN ranked among 99 companies in Chemicals
  • CE ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCCOLNCESPY
1 month +3.3%+16.2%+12.2% -2.0%
3 months -16.2%-8.6%+12.6% -2.8%
6 months -42.6%-34.8%-9.5% +2.0%
Year to date +12.6%-16.2%+21.6% +10.6%
1 year +8.2%-15.9%+28.6% +12.2%
3 years -50.5%-62.8%-59.1% +68.1%
3 years, per year -20.9%-28.1%-25.8% +18.9%
5 years -60.0%-72.9%-69.8% +61.4%
5 years, per year -16.7%-23.0%-21.3% +10.1%
10 years -35.9%-28.4%-33.2% +248.5%
10 years, per year -4.3%-3.3%-4.0% +13.3%

Risk

MeasureCCOLNCESPY
Volatility, 1Y 61.9%52.7%49.6% 13.6%
Downside volatility, 1Y 68.2%54.3%45.5% 13.9%
Beta vs S&P 500, 1Y 1.450.350.50 1.00
Return / volatility, 1Y 0.13-0.300.58 0.90
Max drawdown, 5Y -79.0%-78.0%-79.6% -25.4%
From 52-week high -52.5%-42.1%-25.8% -3.2%
52-week high $27.94$30.14$69.24 $779.14
52-week low $10.48$14.72$35.53 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCCOLNCE
P/E now vs peer median -13.0xmedian 23.4x -8.8xmedian 23.4x 21.5xmedian 23.4x
P/S now vs peer median 0.3xmedian 1.3x 0.3xmedian 1.3x 0.6xmedian 1.3x
EV/EBITDA now vs peer median 14.0xmedian 12.7x 13.7xmedian 12.7x 9.6xmedian 12.7x
P/FCF now vs peer median 9.5xmedian 17.0x 9.0xmedian 17.0x 7.1xmedian 17.0x
P/B now vs peer median 12.8xmedian 1.5x 1.2xmedian 1.5x 1.2xmedian 1.5x
PEG now vs peer median -0.60median 1.72 0.26median 1.72 -0.43median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCCOLNCE
Revenue $5.84B $6.74B $9.85B
Gross profit $885.00M $450.00M $2.05B
Operating income $37.00M -$129.10M $781.00M
Net income -$154.00M -$225.10M $274.00M
Free cash flow $211.00M $221.50M $794.00M
R&D $104.00M – $118.00M
EPS (diluted) $-1.01 $-1.96 $2.38
Cash & equivalents $698.00M $214.80M $1.36B
Total debt $3.83B $3.01B $11.55B
Shares (diluted) 151.91M 115.00M 110.20M
Enterprise value -$711.88M $1.19B -$359.22M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCCOLNCE
P/E -13.0x -8.8x 21.5x
P/FCF 9.5x 9.0x 7.1x
P/Operating cash flow 5.0x 5.1x 5.2x
P/S 0.3x 0.3x 0.6x
P/B 12.8x 1.2x 1.2x
P/Tangible book 13.0x 1.3x 3.5x
EV/EBITDA 14.0x 13.7x 9.6x
EV/EBIT 138.8x -37.1x 20.3x
EV/Revenue 0.9x 0.7x 1.6x
EV/FCF 24.3x 21.6x 19.9x
EV/Operating cash flow 12.8x 12.3x 14.7x
PEG (3Y EPS CAGR) -0.60 0.26 -0.43

Growth

14 metrics
MetricCCOLNCE
Revenue growth (1Y) 0.1% -0.7% 1.6%
Revenue CAGR (3Y) -1.2% -2.2% -2.8%
Gross profit growth (1Y) -12.5% -28.4% -0.3%
Gross profit CAGR (3Y) -10.9% -30.9% -4.8%
Operating income growth (1Y) 1,133% -161.7% 134.0%
Operating income CAGR (3Y) 29.0% -29.0% -19.3%
Net income growth (1Y) 55.9% -531.2% 108.8%
Net income CAGR (3Y) 21.3% -33.4% -48.7%
EPS growth (1Y) 56.3% -520.7% 108.4%
EPS CAGR (3Y) 21.6% -34.1% -49.6%
Operating cash flow growth (1Y) 50.9% 32.6% -22.6%
Operating cash flow CAGR (3Y) 19.4% -26.1% -12.6%
Free cash flow growth (1Y) 1,858% 176.2% -22.5%
Free cash flow CAGR (3Y) 72.7% -32.8% -8.2%

Profitability

14 metrics
MetricCCOLNCE
Gross margin 15.2% 6.7% 20.8%
EBITDA margin 6.3% 5.2% 16.8%
Operating margin 0.6% -1.9% 7.9%
Pretax margin 2.3% -4.4% 3.4%
Net margin -2.6% -3.3% 2.7%
FCF margin 3.6% 3.3% 8.1%
Operating cash flow margin 6.8% 5.8% 10.9%
Return on equity -285.2% -13.1% 6.0%
Return on assets -2.1% -3.0% 1.3%
Return on invested capital 0.0% -2.1% 4.1%
Return on capital employed 0.7% -2.2% 4.6%
Asset turnover 0.8x 0.9x 0.5x
Cash conversion (OCF / net income) -2.6x -1.7x 3.9x
Stock comp / revenue 0.4% 0.3% 0.3%

Financial Health

11 metrics
MetricCCOLNCE
Debt / assets 52.6% 40.7% 55.1%
Debt / equity 24.6x 1.8x 2.5x
Net debt / EBITDA 8.6x 8.0x 6.2x
Debt / FCF 18.2x 13.6x 14.5x
Liabilities / assets 97.9% 76.8% 77.9%
Equity / assets 2.1% 23.2% 22.1%
Interest coverage 0.1x -0.7x 1.1x
Current ratio 1.8x 1.5x 1.3x
Quick ratio 0.9x 0.9x 0.7x
Cash ratio 0.4x 0.1x 0.3x
Altman Z-score 1.43 1.55 1.54

Shareholder Returns

7 metrics
MetricCCOLNCE
Dividend yield 2.7% 4.6% 0.2%
Net buyback yield -0.2% 0.3% –
Shareholder yield 2.5% 4.9% 0.2%
Payout ratio (earnings) -35.1% – 5.1%
Payout ratio (FCF) 25.6% – 1.8%
Dividend growth (1Y) -45.5% – -83.7%
Dividend CAGR (3Y) -28.7% – -64.2%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCCOLNCE
Forward P/E 15.1xFY2026 – 8.0xFY2026
EPS, next fiscal year $0.88FY2026 $-0.59FY2026 $6.46FY2026
EPS growth, next FY -7.4%FY2026 – +62.3%FY2026
EPS growth, the year after +109.1% – -0.3%
Revenue, next fiscal year $5.76BFY2026 $6.35BFY2026 $9.71BFY2026
Revenue growth, next FY -0.9%FY2026 -6.4%FY2026 +1.7%FY2026
Revenue growth, the year after +2.7% +15.3% +8.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCCOLNCE
Held by institutions 89.4% 99.7% 100.0%
Institutions holding 472 413 458
Change in shares held, QoQ +2.8% +1.4% +10.8%
Institutions buying 213 215 246
Institutions selling 127 121 138
Buyers to sellers 1.68 1.78 1.78

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CCOLNCE
CC 1.00 0.47 0.51
OLN 0.47 1.00 0.63
CE 0.51 0.63 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CC, OLN and CE?

Celanese (CE) is the largest by market capitalisation: Chemours (CC) $1.89B, Olin (OLN) $1.94B, Celanese (CE) $5.39B.

Which company is growing faster?

Celanese (CE) grew revenue fastest over the trailing twelve months: Chemours (CC) +0.1%, Olin (OLN) -0.7%, Celanese (CE) +1.6%.

Which company is more profitable?

Celanese (CE) has the highest net margin (Chemours (CC) -2.6%, Olin (OLN) -3.3%, Celanese (CE) 2.7%). On return on invested capital, Celanese (CE) leads (Chemours (CC) 0.0%, Olin (OLN) -2.1%, Celanese (CE) 4.1%).

Which stock has performed better?

Over the past year Celanese (CE) returned the most: Chemours (CC) +8.2%, Olin (OLN) -15.9%, Celanese (CE) +28.6%. Over five years, Chemours (CC) compounded fastest (Chemours (CC) -16.7%/yr, Olin (OLN) -23.0%/yr, Celanese (CE) -21.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Chemours (CC) has the highest dividend yield: Chemours (CC) 0.03%, Olin (OLN) 0.00%, Celanese (CE) 0.00%. Olin (OLN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Celanese (CE) has been the steadiest (Chemours (CC) 61.9%, Olin (OLN) 52.7%, Celanese (CE) 49.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CC, OLN and CE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Celanese (CE) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.